NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Clinical trials for NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New prostate cancer drug safety check for indian patients
Disease control Recruiting nowThis study is checking the safety of darolutamide, a prostate cancer drug, when given alongside standard hormone therapy to men in India. It focuses on men whose prostate cancer hasn't spread but keeps growing despite low testosterone levels. Researchers will monitor for side eff…
Matched conditions: NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE4 • Sponsor: Bayer • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Korean prostate cancer drug safety under watch in major 6-Year study
Disease control Recruiting nowThis study is monitoring the safety of darolutamide, an already approved prostate cancer medication, in 600 Korean patients. Researchers will track side effects and see how well the drug works over time by reviewing patients' medical records during their regular doctor visits. Th…
Matched conditions: NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Sponsor: Bayer • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Massive 5,000-Patient study maps prostate Cancer's Real-World journey
Knowledge-focused Recruiting nowThis study is a large registry that will track 5,000 men in Germany with recurrent or metastatic prostate cancer. Its purpose is to observe and document the real-world treatments doctors choose, how the disease progresses, and how patients' quality of life is affected. It does no…
Matched conditions: NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Sponsor: UroTrials Company (GmbH) • Aim: Knowledge-focused
Last updated Feb 25, 2026 15:07 UTC